GlassScriptPhysician profile
Michelle L Cheloha
NPI 1083637409
$1,505.12
in general payments reported to CMS, 2019-2025
16 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $23.57 · 2021: $34.23 · 2022: $289 · 2023: $341 · 2024: $419 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $956.44 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $157.46 | 2019 | |
| Amgen INC. | $62.44 | 2019-2024 | Repatha, Otezla |
| Supernus Pharmaceuticals, INC. | $50.91 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $41.35 | 2019-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Axsome Therapeutics, INC. | $40.09 | 2023 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $36.85 | 2019-2020 | |
| Novo Nordisk INC | $34.03 | 2025 | Ozempic |
| Pfizer INC. | $28.49 | 2025 | |
| Abbott Laboratories | $20.74 | 2022 | |
| Xeris Pharmaceuticals, INC. | $14.70 | 2023 | Gvoke Hypopen |
| Lundbeck LLC | $13.59 | 2025 | Rexulti |
| Lilly USA, LLC | $12.77 | 2023 | Jardiance |
| Glaxosmithkline, LLC. | $12.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.71 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Cheloha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.